Literature DB >> 14754498

Strongyloides hyper-infection: a case for awareness.

A Potter1, D Stephens, B De Keulenaer.   

Abstract

In patients receiving immunosuppressive therapies, Strongyloides stercoralis can cause a life-threatening septic shock, with multi-organ failure and infestation. Strongyloides hyper-infection should be considered in any immunosuppressed patient who has been exposed to the parasite, even if it is many years since that exposure occurred. Delayed eosinophilia may be a feature and treatment with high doses of anthelmintics may be required. An interesting case of S. stercoralis hyper-infection was recently observed at the Royal Darwin Hospital in tropical, northern Australia. The patient was an 18-year-old female with lupus glomerulonephritis, who was receiving immunosuppression in the form of corticosteroids and pulse cyclophosphamide. The characteristics and intensive-care management of this case, including the use of granulocyte-colony stimulating factor and high-dose ivermectin, are described. The patient, who survived, appears to represent the first reported case of S. stercoralis hyper-infection with suspected myocarditis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14754498     DOI: 10.1179/000349803225002453

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  9 in total

1.  Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis.

Authors:  Ashley M Newberry; David N Williams; William M Stauffer; David R Boulware; Brett R Hendel-Paterson; Patricia F Walker
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

2.  Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology.

Authors:  E Mayayo; V Gomez-Aracil; J Azua-Blanco; J Azua-Romeo; J Capilla; R Mayayo
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

3.  DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.

Authors:  Laura A Kerepesi; Paul B Keiser; Thomas J Nolan; Gerhard A Schad; David Abraham; Thomas B Nutman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy.

Authors:  Eun Jeong Won; Jin Jeon; Young-Il Koh; Dong Wook Ryang
Journal:  Korean J Parasitol       Date:  2015-04-22       Impact factor: 1.341

Review 5.  Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communities.

Authors:  Adrian Miller; Michelle L Smith; Jenni A Judd; Rick Speare
Journal:  PLoS Negl Trop Dis       Date:  2014-09-25

Review 6.  A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review.

Authors:  Ting-Ting Qu; Qing Yang; Mei-Hong Yu; Jie Wang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Disseminated Strongyloidiasis in an Iranian Immunocompromised Patient: A Case Report.

Authors:  Narges Najafi; Eissa Soleymani; Shahabeddin Sarvi; Amirkeivan Marofi; Anahita Nosrati; Alireza Davoodi
Journal:  Iran J Parasitol       Date:  2016 Apr-Jun       Impact factor: 1.012

8.  Azathioprine hypersensitivity presenting as sweet syndrome in a child with ulcerative colitis.

Authors:  Mi Jin Kim; Kee Taek Jang; Yon Ho Choe
Journal:  Indian Pediatr       Date:  2011-12       Impact factor: 1.411

9.  Fatal Strongyloides Hyperinfection Syndrome in an Immunocompromised Patient.

Authors:  Vaishnavi Pochineni; Darshan Lal; Shahed Hasnayen; Erfidia Restrepo
Journal:  Am J Case Rep       Date:  2015-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.